Logo image of CRE.CA

CRITICAL ELEMENTS LITHIUM CO (CRE.CA) Stock Fundamental Analysis

TSX-V:CRE - TSX Venture Exchange - CA22675W1077 - Common Stock - Currency: CAD

0.59  -0.01 (-1.67%)

Fundamental Rating

3

CRE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 822 industry peers in the Metals & Mining industry. The financial health of CRE is average, but there are quite some concerns on its profitability. CRE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CRE was profitable.
In the past year CRE has reported a negative cash flow from operations.
In the past 5 years CRE always reported negative net income.
CRE had a negative operating cash flow in each of the past 5 years.
CRE.CA Yearly Net Income VS EBIT VS OCF VS FCFCRE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

CRE has a better Return On Assets (1.91%) than 88.61% of its industry peers.
The Return On Equity of CRE (2.07%) is better than 87.88% of its industry peers.
Industry RankSector Rank
ROA 1.91%
ROE 2.07%
ROIC N/A
ROA(3y)-4.68%
ROA(5y)-5.01%
ROE(3y)-5.12%
ROE(5y)-5.89%
ROIC(3y)N/A
ROIC(5y)N/A
CRE.CA Yearly ROA, ROE, ROICCRE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CRE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRE.CA Yearly Profit, Operating, Gross MarginsCRE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for CRE remains at a similar level compared to 1 year ago.
The number of shares outstanding for CRE has been increased compared to 5 years ago.
Compared to 1 year ago, CRE has an improved debt to assets ratio.
CRE.CA Yearly Shares OutstandingCRE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CRE.CA Yearly Total Debt VS Total AssetsCRE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

CRE has an Altman-Z score of 11.79. This indicates that CRE is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 11.79, CRE is in the better half of the industry, outperforming 78.06% of the companies in the same industry.
CRE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
CRE has a Debt to Equity ratio (0.00) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11.79
ROIC/WACCN/A
WACCN/A
CRE.CA Yearly LT Debt VS Equity VS FCFCRE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 11.71 indicates that CRE has no problem at all paying its short term obligations.
CRE has a better Current ratio (11.71) than 87.64% of its industry peers.
CRE has a Quick Ratio of 11.71. This indicates that CRE is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CRE (11.71) is better than 87.76% of its industry peers.
Industry RankSector Rank
Current Ratio 11.71
Quick Ratio 11.71
CRE.CA Yearly Current Assets VS Current LiabilitesCRE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 152.21% over the past year.
EPS 1Y (TTM)152.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%248.39%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CRE will show a very strong growth in Earnings Per Share. The EPS will grow by 88.11% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y3.05%
EPS Next 2Y37.48%
EPS Next 3Y236.2%
EPS Next 5Y88.11%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRE.CA Yearly Revenue VS EstimatesCRE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100M 200M 300M 400M 500M
CRE.CA Yearly EPS VS EstimatesCRE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 0.4 0.6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 59.00 indicates a quite expensive valuation of CRE.
Based on the Price/Earnings ratio, CRE is valued cheaper than 87.52% of the companies in the same industry.
CRE is valuated expensively when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
CRE is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 59
Fwd PE N/A
CRE.CA Price Earnings VS Forward Price EarningsCRE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRE.CA Per share dataCRE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CRE does not grow enough to justify the current Price/Earnings ratio.
CRE's earnings are expected to grow with 236.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)19.34
PEG (5Y)N/A
EPS Next 2Y37.48%
EPS Next 3Y236.2%

More info and screens

0

5. Dividend

5.1 Amount

CRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CRITICAL ELEMENTS LITHIUM CO

TSX-V:CRE (3/7/2025, 7:00:00 PM)

0.59

-0.01 (-1.67%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)01-23 2025-01-23
Earnings (Next)N/A N/A
Inst Owners3.24%
Inst Owner ChangeN/A
Ins Owners4.27%
Ins Owner ChangeN/A
Market Cap128.53M
Analysts83.08
Price Target1.61 (172.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.97%
PT rev (3m)-14.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-93.9%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 59
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.72
P/tB 1.72
EV/EBITDA N/A
EPS(TTM)0.01
EY1.69%
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.34
TBVpS0.34
PEG (NY)19.34
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.91%
ROE 2.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.68%
ROA(5y)-5.01%
ROE(3y)-5.12%
ROE(5y)-5.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 14449.6%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.71
Quick Ratio 11.71
Altman-Z 11.79
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)12312.4%
Cap/Depr(5y)9260.33%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%248.39%
EPS Next Y3.05%
EPS Next 2Y37.48%
EPS Next 3Y236.2%
EPS Next 5Y88.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-55.45%
EBIT Next 3Y132.14%
EBIT Next 5Y123.6%
FCF growth 1Y-13.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.08%
OCF growth 3YN/A
OCF growth 5YN/A